Newgenivf Group Limited Stock Volatility Indicators Normalized Average True Range
| NIVF Stock | 1.34 0.25 15.72% |
| Symbol |
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Normalized Average True Range is used to analyze tradable apportunities for NewGenIvf Group across different markets.
NewGenIvf Group Technical Analysis Modules
Most technical analysis of NewGenIvf Group help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for NewGenIvf from various momentum indicators to cycle indicators. When you analyze NewGenIvf charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About NewGenIvf Group Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of NewGenIvf Group Limited. We use our internally-developed statistical techniques to arrive at the intrinsic value of NewGenIvf Group Limited based on widely used predictive technical indicators. In general, we focus on analyzing NewGenIvf Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NewGenIvf Group's daily price indicators and compare them against related drivers, such as volatility indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of NewGenIvf Group's intrinsic value. In addition to deriving basic predictive indicators for NewGenIvf Group, we also check how macroeconomic factors affect NewGenIvf Group price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 20.01 | 2.78 | 3.19 | 3.03 | Days Of Inventory On Hand | 13.34 | 8.18 | 7.36 | 6.06 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NewGenIvf Group's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Be your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Generate Optimal Portfolios
Align your risk and return expectations
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NewGenIvf Group Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Can Health Care Providers & Services industry sustain growth momentum? Does NewGenIvf have expansion opportunities? Factors like these will boost the valuation of NewGenIvf Group. Anticipated expansion of NewGenIvf directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating NewGenIvf Group demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share 4.2 K | Revenue Per Share | Quarterly Revenue Growth (0.13) | Return On Assets | Return On Equity |
Understanding NewGenIvf Group requires distinguishing between market price and book value, where the latter reflects NewGenIvf's accounting equity. The concept of intrinsic value—what NewGenIvf Group's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push NewGenIvf Group's price substantially above or below its fundamental value.
It's important to distinguish between NewGenIvf Group's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding NewGenIvf Group should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, NewGenIvf Group's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.